Study guide
2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes
PTCB Technician Product Verification TPV
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Tech-Check-Tech Verification Fundamentals
1.1 About the PTCB TPV Certificate Exam 1.2 Tech-Check-Tech (TCT) Scope, Regulations, and Quality Assurance 1.3 Systematic Verification Protocol & Visual Inspection Steps
2 Chapter 2: Drug Name Verification & Brand/Generic Identification
2.1 Brand vs Generic Mapping, USAN Stems, and Orange Book Therapeutic Equivalence 2.2 Salt Forms and Active Ingredient Verification 2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes
3 Chapter 3: Auxiliary Labels, REMS & Controlled Substances
3.1 Auxiliary Warning Labels and Mandatory Patient Counseling Triggers 3.2 REMS Programs and Restricted Distribution Medications 3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
4 Chapter 4: Dosage Forms, Release Mechanisms & Administration Routes
4.1 Modified-Release Formulations (ER, XL, SR, DR, CR) and "Do Not Crush" Rules 4.2 Route of Administration Verification: Ophthalmic vs Otic, Oral vs Topical vs Transdermal 4.3 Specialized Delivery Systems: Inhalers (MDI/DPI), ODTs, Solutions vs Suspensions
5 Chapter 5: Strength Verification & Pharmaceutical Calculations
5.1 Unit Conversions (mcg, mg, g) and Preventing Leading/Trailing Zero Errors 5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL) 5.3 Electrolyte Equivalents (mEq vs mg) and Combination Product Strength Verification
6 Chapter 6: High-Alert Medications & Safety Protocols
6.1 ISMP High-Alert Medications and Independent Double-Check Protocols 6.2 Insulin Formulations, Concentrations (U-100, U-500, U-200, U-300), and Pen/Vial Math 6.3 Concentrated Electrolytes, Opioids, Neuromuscular Blockers, and Oral Methotrexate
7 Chapter 7: Look-Alike / Sound-Alike (LASA) Medications
7.1 FDA and ISMP Tall-Man Lettering Principles 7.2 High-Risk Community/Ambulatory LASA Pairs 7.3 High-Risk Institutional/Hospital LASA Pairs & Packaging Traps
8 Chapter 8: Packaging, Expiration, Storage & Special Handling
8.1 Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD) 8.2 Packaging Integrity, Moisture/Light Sensitivity, and FDA Recall Classes 8.3 Temperature Storage Ranges and Vaccine Cold Chain Integrity 8.4 USP <800> Hazardous Drug Identification and Handling Precautions
9 Chapter 9: NDC Conversion, Repackaging & Final Dispensing Checks
9.1 NDC 10-Digit to 11-Digit Conversion (5-4-2 Standardization) 9.2 Unit-Dose Repackaging Standards and USP <795> BUD Guidelines 9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching
2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes
Key Takeaways Explain This Topic AI
Warfarin sodium tablets adhere to a mandatory, universally standardized color scheme across all US manufacturers (1 mg pink, 2 mg lavender, 2.5 mg green, 3 mg tan, 4 mg blue, 5 mg peach, 6 mg teal, 7.5 mg yellow, 10 mg white), remembered via the clinical mnemonic 'Please Let Greg Tell Boys Peach Teal Yellow White'.
Levothyroxine sodium oral tablets follow a distinctive 12-strength color standard (e.g., 25 mcg orange, 50 mcg white, 75 mcg violet, 88 mcg olive, 100 mcg yellow, 112 mcg rose, 125 mcg brown, 137 mcg turquoise, 150 mcg blue, 175 mcg lilac, 200 mcg pink, 300 mcg green) to guard against microgram dosing errors.
The American Academy of Ophthalmology (AAO) standardizes ophthalmic container cap colors (tan = anti-infective, pink = steroid, red = mydriatics/cycloplegics, yellow = beta-blockers, teal = prostaglandin analogs, purple = alpha-2 agonists, orange = carbonic anhydrase inhibitors) to prevent disastrous administration route and therapeutic class errors.
FDA 21 CFR Part 206 mandates that solid oral dosage forms bear unique imprint codes that, with size, shape, and color, identify the active ingredient, strength, and manufacturer; 21 CFR 206.7 exempts only investigational drugs, bioequivalence-study drugs, pharmacist-compounded preparations, and radiopharmaceuticals outright, and sublingual nitroglycerin is not exempt (Nitrostat is coded 'N' plus the strength digit).
Technicians verifying medications must cross-reference physical tablet imprints against high-resolution imaging databases (DailyMed, Lexicomp, Micromedex) rather than relying solely on bottle label descriptions.
Last updated: August 2026
Manufacturer Identification, Visual Cues, and Color Codes
Core Verification Rule: Visual inspection is the final defensive physical barrier against wrong-drug, wrong-strength, and cross-contamination dispensing errors. A verifying technician must examine the physical dosage form—confirming its imprint code, color, shape, size, scoring, and container cap color—against certified compendial standards before releasing the product.
While automated barcode verification catches barcode-to-label mismatches, only human or visual technical product verification (TPV) detects physical tablet mismatches, rogue pills from previous dispensing cycles, damaged dosage forms, and incorrect liquid cap colors.
1. Warfarin Sodium Tablet Color Standardization
Because warfarin sodium (Coumadin, Jantoven) is a high-alert Narrow Therapeutic Index (NTI) oral anticoagulant with extreme risk of life-threatening hemorrhage or thromboembolism, the pharmaceutical industry and the FDA established a nationally standardized color-coding system . Every commercial manufacturer of warfarin in the United States—both brand and generic—must formulate each tablet strength in the identical standardized color.
The Standardized Warfarin Color Matrix
- Strength Standardized Tablet Color Visual Appearance Description Clinical Mnemonic Letter
- 1 mg Pink Light rose / pink P lease
- 2 mg Lavender Light purple / violet L et
- 2.5 mg Green Light apple green G reg
- 3 mg Tan Tan / light brown T ell
- 4 mg Blue Light blue / sky blue B oys
- 5 mg Peach Peach / light orange P each
- 6 mg Teal Blue-green / teal T eal
- 7.5 mg Yellow Bright yellow Y ellow
- 10 mg White Pure white (uncolored) W hite
- The Universal Clinical Mnemonic
To ensure rapid recall during verification, memorizing the first letters in ascending strength order is standard practice: "Please Let Greg Tell Boys Peach Teal Yellow White"
- P - Pink = 1 mg
- L - Lavender = 2 mg
- G - Green = 2.5 mg
- T - Tan = 3 mg
- B - Blue = 4 mg
- P - Peach = 5 mg
- T - Teal = 6 mg
- Y - Yellow = 7.5 mg
- W - White = 10 mg
Important
Why Warfarin Color Matching is Life-or-Death: Anticoagulation clinics and patients routinely adjust warfarin dosages by tablet color (e.g., 'Take one peach tablet on weekdays and half a blue tablet on weekends' ). If a verifying technician fails to notice that 5 mg peach tablets were dispensed instead of 2.5 mg green tablets, the patient will receive a 100% warfarin overdose, leading to severe internal hemorrhage, hematuria, or fatal hemorrhagic stroke.
2. Levothyroxine Sodium Tablet Color Standards
Levothyroxine sodium (Synthroid, Levoxyl, Unithroid) is dosed in micrograms (mcg) . Because a minute 25 mcg dosing error can induce cardiac arrhythmias, osteoporosis, or severe hypothyroidism, major manufacturers follow a consistent color scheme across 12 commercial tablet strengths.
- Strength (mcg) Strength (mg) Standardized Tablet Color High-Yield Verification Alert
- 25 mcg 0.025 mg Orange Easily confused with peach/rose if lighting is dim
- 50 mcg 0.050 mg White Most common starting dose; pure white tablet
- 75 mcg 0.075 mg Violet Light violet / purple
- 88 mcg 0.088 mg Olive Olive green / muted green
- 100 mcg 0.100 mg Yellow Distinct yellow
- 112 mcg 0.112 mg Rose Deep rose / dark pink
- 125 mcg 0.125 mg Brown Light brown / tan
- 137 mcg 0.137 mg Turquoise Deep turquoise / ocean blue
- 150 mcg 0.150 mg Blue Light blue
- 175 mcg 0.175 mg Lilac Lilac / soft lavender
- 200 mcg 0.200 mg Pink Distinct bright pink
- 300 mcg 0.300 mg Green Dark green / forest green (highest strength)
Warning
Microgram vs. Milligram Metric Traps: Technicians must be vigilant when verifying levothyroxine orders written in milligrams vs. micrograms:
- 0.025 mg = 25 mcg (Orange)
- 0.05 mg = 50 mcg (White)
- 0.1 mg = 100 mcg (Yellow)
- 0.2 mg = 200 mcg (Pink)
Confusing 0.025 mg with 0.25 mg (which does not exist, but could be misread as 200 mcg or 300 mcg) results in massive over- or under-dosing.
3. Ophthalmic Bottle Cap Color Coding (AAO Standards)
The American Academy of Ophthalmology (AAO) established an industry-wide cap color standard for topical ophthalmic medications. Because ophthalmic patients frequently suffer from impaired vision, cataracts, or severe glaucoma, cap colors serve as a critical visual safety mechanism.
Cap Color Pharmacological Class Representative Ophthalmic Drug Examples Clinical Mechanism / Alert
Tan Anti-infectives / Antibiotics Ciprofloxacin, Moxifloxacin (Vigamox), Tobramycin (Tobrex), Ofloxacin Treats bacterial keratitis / conjunctivitis
Pink / White with Pink Band Anti-inflammatory / Corticosteroids Prednisolone acetate (Pred Forte), Loteprednol (Lotemax), Dexamethasone Reduces intraocular inflammation; monitor IOP
Red Mydriatics & Cycloplegics Atropine, Cyclopentolate (Cyclogyl), Tropicamide (Mydriacyl) DILATES PUPILS; CRITICAL WARNING: Can precipitate acute angle-closure glaucoma in shallow anterior chambers!
Yellow Beta-blockers (Full Strength 0.5%) Timolol maleate 0.5% (Timoptic), Betaxolol 0.5%, Levobunolol 0.5% Decreases aqueous humor production; systemic bradycardia risk
Light Blue Beta-blockers (Half Strength 0.25%) Timolol maleate 0.25%, Betaxolol 0.25% Lower concentration beta-blocker
Teal (Turquoise) Prostaglandin Analogs Latanoprost (Xalatan), Bimatoprost (Lumigan), Travoprost (Travatan Z) Increases uveoscleral outflow; causes irreversible iris darkening / eyelash growth
Purple Alpha-2 Adrenergic Agonists Brimonidine (Alphagan P), Apraclonidine (Iopidine) Decreases aqueous synthesis and increases uveoscleral outflow
Orange Carbonic Anhydrase Inhibitors (CAIs) Dorzolamide (Trusopt), Brinzolamide (Azopt) Inhibits carbonic anhydrase II; sulfa cross-reactivity warning
Green Miotics / Parasympathomimetics Pilocarpine (Isopto Carpine), Carbachol Constricts pupils (miosis); opens trabecular meshwork
Gray Ophthalmic NSAIDs Ketorolac (Acular), Nepafenac (Nevanac), Bromfenac (Prolensa) Treats post-cataract inflammation and ocular pain Ophthalmic Verification Check: Route MUST BE 'FOR THE EYE ONLY' (Ophthalmic)
- NEVER dispense Otic (ear) drops for Ophthalmic use (Otic drops are non-sterile and acidic!)
- 4. Solid Oral Dosage Form Physical Markings & Imprint Mandate
- FDA Imprint Code Regulation (21 CFR Part 206)
Under federal law ( 21 CFR § 206.10 ), no commercial solid oral drug product (prescription or over-the-counter tablet, capsule, or caplet) may be introduced into interstate commerce unless it bears a clearly readable, unique debossed, embossed, or printed imprint code .
The Elements of the Imprint Code
An imprint code consists of any single letter, number, word, mark, symbol, or logo—or any combination thereof—that, when combined with the product's size, shape, and color , enables unequivocal identification of the active drug moiety, strength, and manufacturer/distributor .
Debossed Imprint: Imprinted into the tablet surface during compression using engraved punches.
Embossed Imprint: Raised above the surface of the tablet.
Printed Imprint: Applied using food-grade pharmaceutical ink onto film-coated tablets or hard/soft gelatin capsule shells.
Exemptions Under 21 CFR § 206.7
21 CFR § 206.7 — not § 206.10 — is where the exemptions live, and it names categories , never individual drug products.
Categorically exempt (no application needed):
Drug products intended for use in a clinical investigation under section 505(i) of the Act, other than treatment INDs.
Drugs, other than reference listed drugs, intended for use in bioequivalence studies.
Drugs extemporaneously compounded by a licensed pharmacist for an individual patient.
Radiopharmaceutical drug products.
Exempt only on a granted request:
Products whose size, shape, texture, or other physical characteristics make imprinting technologically infeasible or impossible — the applicant must request the exemption in writing from the appropriate CDER or CBER review division.
Products administered solely in controlled health care settings and not provided to patients for self-administration — also by written request.
Caution
Do not repeat the sublingual-nitroglycerin myth. A very common claim in technician study material is that sublingual nitroglycerin is exempt from imprinting because it is too small and too volatile. It is not exempt, and it is not unimprinted. Per the current Nitrostat labeling, the tablets are white, round, flat-faced, and coded "N" on one side with the strength digit on the other : N / 3 for 0.3 mg, N / 4 for 0.4 mg, and N / 6 for 0.6 mg. When a physical dosage form is genuinely unimprinted, the realistic explanations are that it is a compounded preparation, an investigational product, or a radiopharmaceutical — not that "small tablets are exempt."
5. Visual Inspection Protocol & Database Verification
During technical product verification, verifying technicians must execute a structured 5-point physical inspection:
Imprint Verification: Read the exact characters on both sides of the solid dosage form (e.g., 'M / 30', 'IP 109', 'TV / 58', 'WATSON / 853'). Look up the imprint code in a certified compendial database:
- DailyMed (National Library of Medicine / official FDA package labels)
- Lexicomp / Micromedex / Facts & Comparisons / Ident-A-Drug
Shape & Contour Check: Verify whether the dosage form is round, oval, oblong/capsule-shaped, triangular, square, biconvex, or flat-faced.
Color & Coating Check: Inspect for accurate shade (e.g., lavender vs pink), coating type (film-coated vs enteric-coated vs sugar-coated), and uniformity (no mottling, speckling, or discoloration).
Scoring Verification: Check whether the tablet is unscored, single-scored (bisected), or quadrisected. If a prescription specifies taking half-tablets, the dispensed tablet must be FDA-approved as scoreable.
Dosage Form Integrity & Debris Check: Inspect the counting tray or unit-dose packaging for chipped tablets, capped tablets (top splitting off), excessive powder/friability, moisture degradation, or foreign 'rogue' tablets accidentally dropped from an earlier prescription fill.